HCP5 and gastric cancer: Subsequently, we investigated whether HCP5‐132aa, through the RNA binding protein function of YBX1, modulated the fate and function of its downstream target mRNA at the post‐transcriptional level and thereby promoted the malignant phenotype of GC cells.